相关实验视频

Updated: Sep 13, 2025

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

卢泰林向过氧素2以增加T细胞介导的细胞毒性,并抑制肺腺癌的进展

Xuan Li¹, Ying Bai¹, Jiawei Zhou²

¹School of Medicine, Anhui University of Science and Technology, Huainan, 232000, Anhui, China; Anhui Occupational Health and Safety Engineering Laboratory, Huainan, 232000, Anhui, China.

European journal of pharmacology

|July 25, 2025

概括

素有效地通过向Peroxiredoxin-2 (PRDX2) 来抑制肺腺癌 (LUAD) 的进展. 这种天然化合物促进癌细胞亡,增强抗瘤免疫力,提供了一个有前途的治疗策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

肺腺癌 (LUAD) 是一个主要的全球健康问题,死亡率高.
Peroxiredoxin-2 (PRDX2) 在LUAD组织中过度表达,呈现出潜在的治疗标.
从传统中医药中识别PRDX2的低毒性抑制剂是一项挑战.

研究的目的:

为了确定潜在的PRDX2抑制剂用于LUAD治疗.
阐明已识别的抑制剂的作用机制.
在临床前模型中评估黄素的治疗疗效.

主要方法:

分子对接和热转移测试以评估素-PRDX2相互作用.
在体外基于细胞的增殖和迁移测定.
瘤生长抑制的体内小鼠模型.
流细胞测量和西方斑点用于机械学研究.

主要成果:

氨酸对PRDX2.2表现出强烈的结合亲和力.
丁醇在体外显著抑制了LUAD细胞的增殖和迁移.
素抑制了体内瘤的生长,并促进了癌细胞的亡.
素通过抑制JAK2 / STAT3通路和PD-L1表达来增强CD8 + T细胞介导的杀死.

结论:

氨酸作为PRDX2抑制剂,为LUAD提供了一种新的治疗方法.
素的机制包括增强抗瘤免疫力和减少免疫逃避.
素显示出作为低毒性,有效治疗肺腺癌的潜力.

关键词:

肺部腺癌瘤是肺部腺癌.卢特奥林是什么意思?卢特奥林是什么意思?过氧化素 2 2 过氧化素一个T细胞细胞.

更多相关视频

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms: